Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast 620: #Stocks discussed: (Nasdaq: $KLAC) (Nasdaq: $LTRN) #artificialintelligence

Monday, November 01, 2021

#AIEye #Podcast 620: #Stocks discussed: (Nasdaq: $KLAC) (Nasdaq: $LTRN) #artificialintelligence

#AIEye #Podcast 620: #Stocks discussed: (Nasdaq: $KLAC) (Nasdaq: $LTRN) #artificialintelligence

KLA Corporation Opening AI Advanced Computing Lab in India, and Lantern Pharma’s RADR AI Platform Exceeds 10.4 Billion Datapoints

Conversational #AI Market to Reach $18.4B by 2026

Point Roberts WA, Vancouver BC – November 1, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/110121-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/11011KLAC-LTRN.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:KLAC) (NasdaqCM:LTRN)

KLA Corporation (NasdaqGS:KLAC) has announced the opening of two facilities in Chennai, India, including the Artificial Intelligence-Advanced Computing Lab (AI-ACL) – operated in partnership with the Indian Institute of Technology (IIT) Madras – which “will serve as a center of excellence for AI-focused research and development.” Ahmad Khan, president, semiconductor process control at KLA, said:

"KLA is at the forefront of using AI technology in our process control systems to identify and isolate critical issues in chip manufacturing. To expand the reach of AI in our products and develop the next generation of AI innovations, we created our new AI-ACL research facility. Our researchers and engineers at AI-ACL join the AI experts at our AI Modeling and Center of Excellence in Michigan to form a global team committed to advancing the boundaries of AI, software, image processing and physics modeling."

Lantern Pharma Inc. (NasdaqCM:LTRN) has announced that its proprietary A.I. platform RADR – which is used to “transform the cost, pace, and timeline of oncology drug discovery and development” – has exceeded 10.4 billion datapoints. The company’s President and CEO, Panna Sharma, explained:

"Our team has been well ahead of schedule in the growth of our platform, and RADR^® has now surpassed 10.4 billion data points covering more cancer sub-types, which further advances our goal of building the most complete and powerful A.I. platform for precision oncology drug development. Additionally, the new data will drive insights and potential drug-candidate innovations faster and into areas of cancer that have remained untouched or intractable."

Conversational AI Market to Reach $18.4B by 2026

A report published by Markets and Markets finds that the global Conversational AI market is projected to grow from $6.8 billion in 2021 to $18.4 billion by 2026, registering a compound annual growth rate (CAGR) of 21.8 percent in the forecast period. An excerpt from the report’s description outlines factors influencing the market’s growth:

The major factors driving the growth of the conversational AI market are the increasing demand for AI-powered customer support services, omnichannel deployment, and reduced chatbot development costs. Furthermore, the rising demand for AI-based chatbots to stay connected and informed during COVID-19 and increasing focus on customer engagement are the major factors adding value to the conversational AI offerings, which is expected to provide opportunities for enterprises operating in various verticals in the conversational AI market. The lack of accuracy in chatbots and virtual assistants and maintaining business continuity during the COVID-19 pandemic are the major challenges in the conversational AI market. Moreover, the lack of awareness about conversational AI solutions and the inability to identify customer intent and respond effectively act as the key restraining factors in the market.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.

The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com